NEWS
EDITOR'S MESSAGE
Internet to the Infinite Power
THE LAST WORD
"Physician Wars" Heat Up (Again)
Tough economic times can bring out human nature at its worst
Triple Threat
J. Peter Rubin, MD, FACS, has a clinical practice, does cutting-edge research, teaches, and lends his expertise to medical conferences and societies around the globe
EDITOR'S MESSAGE
Where There Is a Will, There Is a Way
INDEPTH
Abdominoplasty Technique Offers New Mothers Their "Pre-Baby" Figures
Botox Type Cream Gets Patent Approval
Emergent Health Corp this week announced the patent under which it has a license to market a painless Botox type cream, which does not require an injection.
11/19/2008
Canady Named New ASPS President
John W. Canady, MD, professor in the Plastic and Reconstructive Surgery department at the University of Iowa, has been named the president of the American Society of Plastic Surgeons (ASPS).
11/18/2008
Study Suggests New Treatment for Melasma
Researchers from Yongdong Severance Hospital, Yonsei University College of Medicine in Seoul, South Korea, have released a study that says reducing the vascular endothelial growth factor (VEGF) seems to be an excellent approach in successfully treating melasma and significantly reducing hyperpigmentation.
11/17/2008
Robotic-Assisted Neck Surgery Eliminates Incision, Scar
Surgeons at the University of Illinois Medical Center at Chicago have performed a robotic-assisted procedure to remove parathyroid glands without an incision or scar on the patient's neck.
11/13/2008
ASPS: Looks May Matter Less in This Economy
At the Plastic Surgery 2008 meeting held last week in Chicago, the American Society of Plastic Surgeons (ASPS) reported the results of its recent survey, in which 48% of women considering cosmetic surgery polled in October said they were less likely to schedule a consultation, up from 30% in March.
11/12/2008
Revascularization seldom of benefit for asymptomatic carotid stenosis
NEW YORK (Reuters Health) - With the introduction of more intensive medical therapy, revascularization for asymptomatic carotid stenosis is likely to benefit less than 5% of patients, according to the results of a study presented Thursday at the 6th World Stroke Congress in Vienna, Austria.
9/25/2008 12:00:21 AM
Liraglutide superior to glimepiride for glycemic control in type 2 diabetes
NEW YORK (Reuters Health) - Liraglutide (Novo Nordisk) is more effective than the sulfonylurea glimepiride in reducing HbA1c in patients with type 2 diabetes, according to 1-year results of the phase III Liraglutide Effect and Action in Diabetes (LEAD-3 Mono) study.
9/24/2008 6:30:19 PM
Drug-eluting stents in acute MI cut mortality, repeat revascularizations
NEW YORK (Reuters Health) - As a treatment for acute MI, percutaneous coronary intervention (PCI) with a drug-eluting stent rather than with a bare-metal stent reduces 2-year mortality and the need for repeat revascularization, according to a report in The New England Journal of Medicine for September 25.
9/24/2008 5:00:26 PM
Increasing BMI may impact choice of prostate cancer treatment
NEW YORK (Reuters Health) - Obese patients with prostate cancer appear to be more likely to receive nonsurgical treatments than their normal weight counterparts, research shows.
9/24/2008 1:17:17 PM
Drug-eluting stents cut mortality in "real-world" setting
NEW YORK (Reuters Health) - Randomized trials have shown a survival benefit to using drug-eluting stents (DES) rather than bare-metal stents (BMS) in heart disease patients. Now, the results of a single-center observational study suggest that this survival benefit also extends to the "real-world" setting.
9/24/2008 8:30:16 AM
LOOKING FOR EXPERT ADVICE?
|
 |
|
Experts here are available to answer all your questions!
